Table 3 Adverse Outcome Characteristics
Outcome | Number of events | Incidence rate | Age of onset | Number of pre-existing comorbidities | Mean onset in follow-up (days) |
|---|---|---|---|---|---|
Mortality | 12,372 | 49.12% | 69.7 ± 12.0 | 2.71 ± 1.66 | 3056 ± 1396 |
Renal | 5389 | 21.40% | 66.5 ± 12.2 | 3.51 ± 1.67 | 3500 ± 1367 |
Ophthalmological | 4705 | 18.68% | 62.8 ± 11.9 | 3.11 ± 1.81 | 3590 ± 1296 |
Ischemic Heart Disease | 4532 | 17.99% | 66.8 ± 11.6 | 3.70 ± 1.74 | 3700 ± 1119 |
Acute myocardial infarction | 3178 | 12.62% | 68.3 ± 11.1 | 4.15 ± 1.59 | 3882 ± 859 |
Neurological | 1861 | 7.39% | 64.2 ± 11.9 | 4.03 ± 1.77 | 3952 ± 835 |
Atrial Fibrillation | 1846 | 7.33% | 70.4 ± 10.3 | 3.75 ± 1.74 | 3993 ± 715 |
Heart Failure | 1810 | 7.19% | 68.9 ± 11.4 | 4.61 ± 1.45 | 3993 ± 711 |
Ischemic Stroke | 1350 | 5.36% | 69.2 ± 10.9 | 3.55 ± 1.79 | 4037 ± 634 |
Intracranial Hemorrhage | 1049 | 4.17% | 68.4 ± 11.7 | 3.45 ± 1.67 | 4075 ± 530 |
Dementia | 952 | 3.78% | 74.4 ± 8.30 | 3.37 ± 1.68 | 4077 ± 535 |
Peripheral vascular disease | 711 | 2.82% | 66.6 ± 12.4 | 4.39 ± 1.85 | 4094 ± 505 |
Osteoporosis | 275 | 1.09% | 72.1 ± 11.3 | 3.01 ± 1.68 | 4146 ± 299 |